…ing insulin analogues in patients with type 1 diabetes (T1D) or type 2 diabetes (T2D).Design, setting This retrospective cohort study used data…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 36 of 2459…ously evaluated in patients with advanced melanoma treated with nivolumab plus ipilimumab. This analysis compared TFS for nivolumab plus …
… technological and cultural solutions are key to mitigation. As RA becomes increasingly central to modern surgical care, ensuring …
…for paediatric UC patients appears to yield similar outcomes to Infliximab. Given these findings, weighing cost-effectiveness and the bene…
…tes (SGLT-2 inhibitors, GLP-1 receptor agonists, finerenone and tirzepatide):• Lower risk (three or fewer cardiovascular risk factors witho…
…on, occupation, and country of birth were collected, as well as diabetes duration, insulin administration (insulin pump, continuous subc…
…ioeconomic markers, and stroke severity.Results Among 3,209,635 stroke hospitalizations, 620,605 (19.3%) had private insurance, 329,23…
…Group’s Youth instruments with three and five response options (EQ-5D-Y-3L and EQ-5D-Y-5L), Child Health Utility 9D (CHU9D), Assessme…
… either mean (+/- standard deviation) or median (range).Results Nocturia was associated with age (p = 0.034), ODI (p = 0.035), and % tim…
… window (>300x based on 14-day non-GLP tox studies).Conclusions LUS012, a highly selective Kv1.3 inhibitor with gut-restricted exposur…
…tudy, performed between September 2022 - January 2026, eligible PWH were stratified into low, intermediate, or high VF risk as desc…
…sue infection (SSTI), urinary tract infection (UTI), sepsis and meningitis/encephalitis (positive control exposure) recorded in primary care were match…